Table 2 Level of effort needed to overcome some of the drawbacks of the risk-sharing agreements
From: Implementation of risk-sharing contracts as perceived by Spanish hospital pharmacists
Drawbacks | Type of agreement | |||||
|---|---|---|---|---|---|---|
Price-volume | Other | |||||
Low | Medium | High | Low | Medium | High | |
Keeping patient records | 32.1% | 62.5% | 5.4% | 29.4% | 47.1% | 23.5% |
Persuading clinicians to prescribe the drugs included in the agreements | 46.4% | 51.8% | 1.8% | 35.3% | 58.8% | 5.9% |
Building or adapting information systems to manage the agreements | 5.4% | 80.4% | 14.3% | 5.9% | 52.9% | 41.2% |
Administrative and legal bureaucracy involved in drawing up the agreements | 3.6% | 76.8% | 19.6% | 29.4% | 29.4% | 41.2% |
Decision about the cost-effectiveness threshold or sales threshold for price reductions and savings | 16.1% | 60.7% | 23.2% | 17.6% | 47.1% | 35.3% |
Administrative follow-up to guarantee compliance with the agreement | 7.1% | 78.6% | 14.3% | 5.9% | 58.8% | 35.3% |